Clinical trial
A 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients…
NCT00002278 · Janssen, LP, Industry · Completed
Key facts
| NCT number | NCT00002278 |
|---|---|
| Title | A 28-Day Study of Diclazuril in the Treatment of Cryptosporidiosis in Patients With AIDS |
| Official title | 28 Day Protocol for the Treatment of Cryptosporidiosis in AIDS Patients With Diclazuril (R64,433) |
| Lead sponsor | Janssen, LP, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Cryptosporidiosis, HIV Infections |
| Intervention type | Drug |
| Interventions | Diclazuril |
| First posted | Aug 31, 2001 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: